Evidence map›Paper›PMID 28900820›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2018

Outcome of childhood leukaemia survivors and necrosis of the femoral head treated with autologous mesenchymal stem cells.

T de Rojas, S Martínez-Álvarez, S Lerma-Lara, M Á Díaz, L Madero, M Ramírez

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

T de RojasPaediatric Oncology Hematology and Stem Cell Transplant, University Hospital Niño Jesús, Av. Menéndez Pelayo, 65, 28009, Madrid, Spain.
S Martínez-ÁlvarezOrthopedics and Traumatology Department, University Hospital Niño Jesús, Av. Menéndez Pelayo, 65, 28009, Madrid, Spain.
S Lerma-LaraGait Analysis Laboratory, University Hospital Niño Jesús, Av. Menéndez Pelayo, 65, 28009, Madrid, Spain.
M Á DíazPaediatric Oncology Hematology and Stem Cell Transplant, University Hospital Niño Jesús, Av. Menéndez Pelayo, 65, 28009, Madrid, Spain.
L MaderoPaediatric Oncology Hematology and Stem Cell Transplant, University Hospital Niño Jesús, Av. Menéndez Pelayo, 65, 28009, Madrid, Spain.
M RamírezPaediatric Oncology Hematology and Stem Cell Transplant, University Hospital Niño Jesús, Av. Menéndez Pelayo, 65, 28009, Madrid, Spain. manuel.ramirez@salud.madrid.org.ORCID http://orcid.org/0000-0003-0332-6973
Hospital Universitario de La Princesa · ESMenéndez Pelayo International University · ES

Funding

Instituto de Salud Carlos III P2010/BMD-2420
6 · The paper itself

Abstract

purposeCorticoid-induced osteonecrosis (ON) of femoral head can lead to severe hip joint impairment and hip replacement, with negative impact in young survivors of acute lymphoblastic leukaemia (ALL) with long life expectancy. We aim to improve quality of life in these patients with a novel approach. METHODS/PATIENTS: Based on the regenerative capacities of mesenchymal stem cells (MSCs), we performed locally implanted autologous cell therapy in two adolescents suffering of bilateral femoral ON. This required a simple, minimally invasive surgical procedure.

resultsBoth patients experienced significant pain relief and restoration of gait kinematic values. Radiographic evaluation showed cessation of hip collapse. No toxicities/complications were observed after a 4-year follow-up.

conclusionsOur preliminary results suggest that autologous MSCs can be considered as a novel treatment for children and young adults with ON after overcoming ALL. It may avoid hip replacement and improve quality of life of leukaemia survivors.

Indexed as

Antineoplastic Agents, HormonalFemaleFemur Head NecrosisGlucocorticoidsHumansMaleMesenchymal Stem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvivorsTreatment OutcomeYoung AdultAntineoplastic Agents, HormonalGlucocorticoidsAcute lymphoblastic leukaemiaCell therapyChildrenMesenchymal stem cellsNecrosis of the femoral headOsteonecrosis

Identifiers

PMID28900820
OpenAlexW2754850398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.